TABLE 1.
MUTATION | NUMBER OF CASES CURRENTLY IDENTIFIED | CLINICAL MANIFESTATION | REFERENCE | |
---|---|---|---|---|
XLT |
|
|
|
|
XLTT | R216Q | 4 families with at least 9 affected individuals# | Macrothrombocytopenia, mild, hemolytic anemia with β decreased β chain production resembling mild β-thalassemia, splenomegaly | Raskind. et al., 2000; Yu. et al.,2002; Balduini. et al., 2004 Hughan et al., 2005# Raskind unpublished. |
XLTT/X-GPS* | R216Q | 1 known case caused by R216Q, total cases of all categories, unknown | Variable, mild bleeding diathesis, thrombocytopenia and large, agranular, functionally abnormal platelets. | Tubman et al., 2007 |
CEP | R216W | 1 known case caused by R216W, total cases of all categories, unknown | Photosensitive bullous dermatosis, hypochromic, microcytic anemia, and thrombocytopenia, splenomegaly, hirsutism | Phillips et al., 2007 |
TMD and DS-AMKL | Somatic, splice mutation in exon 2 of GATA-1, leading to the production of GATA-1s | TMD: 10% of all DS cases DS-AMKL: 30% of TMD cases progress | Hypercellular bone marrow with anemia, thrombocytopenia, and decreased leukocytes predisposing to bleeding disorders and infection | Ahmed et al., 2004, Wechsler et al., 2002; Hitzler and Zipursky, 2005 |
Macrocytic anemia with variable neutropenia | Inherited GATA-1 splice mutation | 1 family with 7 affected individuals | Macrocytic anemia, variable neutropenia, trilineage dysplasia in the bone marrow. infection, anemia, and platelet disorders | Hollanda et al., 2006 |
A single affected male is described in this report with reference to other family members
Naming is currently in debate although this appears to be another family with XLTT and not a separate syndrome.